Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01039987 · ClinicalTrials.gov registry record
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
A clinical trial of Autosomal Dominant Polycystic Kidney Disease, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 211
- Enrollment target
- 5
- Study locations
NCT01039987 is a study of Autosomal Dominant Polycystic Kidney Disease that has completed, run by University of Pittsburgh. The registered enrollment target is 211 participants, above the 138-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (53% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT01039987, a study of Autosomal Dominant Polycystic Kidney Disease, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for a consortium of participating clinical centers (PCCs) and a data coordinating and imaging analysis center (DCIAC) to develop and implement studies to test whether imaging techniques can provide accurate and reproducible markers of progression of renal disease in patients with polycystic kidney disease. The awarded participating clinical centers are Emory University, University of Kansas, and Mayo Foundation (with a subcontract to the University of Alabama). The awarded DCIAC is Washington University in St. Louis. Due to the relocation of the DCIAC P.I. from Washington University to the University of Pittsburgh, the DCIAC for CRISP II is located at the University of Pittsburgh.
Conditions Studied
Study Locations (5)
Alabama
- University of Alabama-Birmingham - Birmingham
Georgia
- Emory University - Atlanta
Kansas
- University of Kansas - Kansas City
Minnesota
- Mayo Clinic - Rochester
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 1999-09 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01039987
The ClinicalTrials.gov registry entry for NCT01039987 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 138-participant average among 9 other Autosomal Dominant Polycystic Kidney Disease trials with a reported enrollment target (53% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autosomal Dominant Polycystic Kidney Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01039987 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Georgia, Kansas.
Frequently Asked Questions
What is clinical trial NCT01039987 about?
NCT01039987 is a clinical study titled "Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease". The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for a consortium of participating clinical centers (PCCs) and a data coordinating and imaging analysis center (DCIAC) to ...
What is the current status of trial NCT01039987?
This trial is currently completed. The enrollment target is 211 participants. The study started on 1999-09. Estimated completion is 2011-03.
What conditions does trial NCT01039987 study?
This clinical trial studies the following conditions: Autosomal Dominant Polycystic Kidney Disease.
Who is sponsoring clinical trial NCT01039987?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01039987 being conducted?
This trial has 5 study locations across Alabama, Georgia, Kansas, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autosomal Dominant Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING
-
NOX4 and Related Biomarkers in ADPKD
RECRUITING
-
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
RECRUITING · Phase 2
-
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
RECRUITING · Phase 1
-
A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
ACTIVE NOT RECRUITING
-
Intrarenal Microvasculature in ADPKD
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.